As the respiratory virus season arrives in the United States, health officials are urging the public to get vaccinated, with October being a prime time to do so. Vaccines for Covid-19, flu, and RSV are readily available, offering protection throughout the season.
It is important to note that it takes about two weeks for the body to develop a complete immune response post-vaccination. However, the benefits of vaccination can last for months, providing a shield against respiratory illnesses.
With Covid-19 already circulating at high levels in the US and flu season approaching, experts are emphasizing the significance of vaccination. The Council of State and Territorial Epidemiologists Executive Director, Janet Hamilton, stresses the importance of getting vaccinated early to safeguard against respiratory diseases.
Forecasts from the US Centers for Disease Control and Prevention indicate that this respiratory disease season may mirror the previous year, which saw a significant number of hospitalizations. The CDC reported over 200 child deaths from flu during the 2023-24 season, underscoring the severity of these illnesses.
A recent study by the CDC revealed that the Southern Hemisphere seasonal flu vaccine reduced the risk of influenza-associated hospitalization among high-risk groups by 35%. This suggests that similar efficacy could be expected if comparable flu viruses circulate in the Northern Hemisphere.
Vaccination rates will play a crucial role in determining the course of illnesses during this season. Hamilton emphasizes that fall respiratory disease vaccines are instrumental in limiting severe infections, reducing hospitalizations, and minimizing the duration of illness.
As the public navigates the respiratory virus season, staying informed about available vaccines is essential for personal protection. By taking proactive measures such as vaccination, individuals can contribute to mitigating the impact of respiratory illnesses in the community.
